A highly contagious disease is spreading among farmed and wild tilapia. Although not a human health risk, Tilapia Lake Virus has large potential impact on global food security and nutrition.
The FAO warns that the outbreak should be treated with concern and countries importing tilapias should take appropriate risk-management measures – intensifying diagnostics testing, enforcing health certificates, deploying quarantine measures and developing contingency plans – according to a Special Alert released by FAO’s Global Information and Early Warnings System.
Tilapia Lake Virus (TiLV) has now been reported in five countries on three continents: Colombia, Ecuador, Egypt, Israel and Thailand.
While the pathogen poses no public health concern, it can decimate infected populations. In 2015, world tilapia production, from both aquaculture and capture, amounted to 6.4 million tonnes, with an estimated value of USD 9.8 billion, and worldwide trade was valued at USD1.8 billion.
Tilapia producing countries need to be vigilant, and should follow aquatic animal-health code protocols of the World Organisation for Animal Health (OIE) when trading tilapia. They should initiate an active surveillance programme to determine the presence or absence of TiLV, the geographic extent of the infection and identify risk factors that may help contain it.
Countries are encouraged also to launch public information campaigns to advise aquaculturists – many of them smallholders – of TiLV’s clinical signs and the economic and social risks it poses and the need to flag large-scale mortalities to biosecurity authorities.
Currently, actively TiLV surveillance is being conducted in China, India, Indonesia and it is planned to start in the Philippines. In Israel, an epidemiological retrospective survey is expected to determine factors influencing low survival rates and overall mortalities including relative importance of TiLV. In addition, a private company is currently working on the development of live attenuated vaccine for TiLV.
It is not currently known whether the disease can be transmitted via frozen tilapia products
FAO will continue to monitor TiLV, work with governments and development partners and search for resources that can be explored in order to assist FAO member countries to deal with TiLV, as requested and as necessary.
More research is required to determine whether TiLV is carried by non-tilapine species and other organisms such as piscivorous birds and mammals, and whether it can be transmitted through frozen tilapia products.
The disease shows highly variable mortality, with outbreaks in Thailand triggering the deaths of up to 90% of stocks. Infected fish often show loss of appetite, slow movements, dermal lesions and ulcers, ocular abnormalities, and opacity of lens.As a reliable diagnostic test for TiLV is available, it should be applied to rule out TiLV as the causal agent of unexplained mortalities.
TiLV belongs to the Orthomyxoviridae family of viruses, which is also the same family to which the Infectious Salmon Anaemia virus belongs, which wrought great damage on the salmon farming industry.
Tilapias are the second most important aquaculture species in volume terms, providing food, jobs and domestic and export earnings for millions of people, including many smallholders.
Their affordable price, omnivorous diet, tolerance to high-density farming methods and usually strong resistance to disease makes them an important protein source, especially in developing countries and for poorer consumers.
China, Indonesia and Egypt are the three leading aquaculture producers of tilapia, a fish deemed to have great potential for expansion in sub-Saharan Africa.
1
.
2
.
3
.
http://www.fao.org/3/a-i7326e.pdf
